WP

Ward M. Peterson

IP Inspire Pharmaceuticals: 21 patents #5 of 76Top 7%
UM Universidad Complutense De Madrid: 1 patents #9 of 112Top 9%
📍 Durham, NC: #203 of 4,103 inventorsTop 5%
🗺 North Carolina: #2,005 of 45,564 inventorsTop 5%
Overall (All Time): #192,069 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12017994 Compounds, compositions, and methods for selectively inhibiting β-glucuronidases and alleviating side effects associated with drug treatment induced diarrhea Francis Xavier Tavares, Bret D. Wallace 2024-06-25
8604205 Cytoskeletal active rho kinase inhibitor compounds, composition and use John W. Lampe, Paul S. Watson, David J. Slade, Christopher S. Crean, Jason L. Vittitow +2 more 2013-12-10
8604218 Cytoskeletal active rho kinase inhibitor compounds, composition and use John W. Lampe, Paul S. Watson, David J. Slade, Christopher S. Crean, Jason L. Vittitow +2 more 2013-12-10
8410147 Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds John W. Lampe, Tomas Navratil, Scott D. Sorensen, Emilee H. Fulcher 2013-04-02
8299096 Method for treating pulmonary diseases using rho kinase inhibitor compounds Tomas Navratil, John W. Lampe, Emilee H. Fulcher, Scott D. Sorensen 2012-10-30
8207195 Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds Tomas Navratil, John W. Lampe, Emilee H. Fulcher 2012-06-26
8071779 Cytoskeletal active rho kinase inhibitor compounds, composition and use John W. Lampe, Paul S. Watson, David J. Slade, Christopher S. Crean, Jason L. Vittitow +2 more 2011-12-06
8008274 P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis Benjamin R. Yerxa, Janet L. Rideout, William Pendergast 2011-08-30
7612047 Degradation-resistant mononucleoside phosphate compounds James G. Douglass, III, Benjamin R. Yerxa, Sammy R. Shaver, Edward G. Brown, Christopher S. Crean +1 more 2009-11-03
7531525 P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis Benjamin R. Yerxa, Janet L. Rideout, William Pendergast 2009-05-12
7435724 Degradation-resistant mononucleoside phosphate compounds James G. Douglass, III, Benjamin R. Yerxa, Sammy R. Shaver, Edward G. Brown, Christopher S. Crean +1 more 2008-10-14
7256183 Method for treating or preventing inflammatory diseases Benjamin R. Yerxa 2007-08-14
7223744 Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof Benjamin R. Yerxa, Janet L. Rideout, William Pendergast 2007-05-29
7115585 Compositions for treating epithelial and retinal tissue diseases Benjamin R. Yerxa, James G. Douglass, III, Sammy R. Shaver, Edward G. Brown, Christopher S. Crean 2006-10-03
7084128 Method for reducing intraocular pressure Benjamin R. Yerxa, Robert Plourde, Jr., Edward G. Brown 2006-08-01
7078391 Method of treating edematous retinal disorders Benjamin R. Yerxa 2006-07-18
6881725 Method for treating pain Benjamin R. Yerxa, Christopher S. Crean 2005-04-19
6864243 Method for treating retinal degeneration with purinergic receptor agonists 2005-03-08
6818629 Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate Benjamin R. Yerxa 2004-11-16
6730707 Method for reducing intraocular pressure using indole derivatives Jesus Jeronimo Pintor, Maria Peral, Robert Plourde, Jr., Edward G. Brown, Benjamin R. Yerxa 2004-05-04
6624150 Method of treating gastrointestinal tract disease with purinergic receptor agonists Benjamin R. Yerxa, Janet L. Rideout, William Pendergast, Sammy R. Shaver, Zhen Zhang +1 more 2003-09-23
6596725 Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema Benjamin R. Yerxa 2003-07-22